Clinical trial

Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis

NCT00497952

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2007-07-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2007-07-01Date precision: month

Registry last updated2023-10-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

hematopoetic stem cell infusionBIOLOGICAL

Sponsors & collaborators

Talaris Therapeutics Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00497952 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.